| Name | 9-[3-(propan-2-ylamino)propyl]fluorene-9-carboxamide |
|---|---|
| Synonyms |
Ricainid
Indecainidum Ricainide INDECAINIDE Indecainida Decabid |
| Description | Indecainide (Ricainide) is an orally active antiarrhythmic agent. Indecainide can be used in the research of ventricular dysfunction[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Indecainide (1-5 mg/kg, i.v.) shows antiarrhythmic effect in dogs[1]. Indecainide (4 mg/kg, p.o.) results in rapid absorption by 15 min[2]. Animal Model: Dogs[1] Dosage: 1-5 mg/kg Administration: Intravenous injection Result: Decreased cardiac contractility. |
| Density | 1.109g/cm3 |
|---|---|
| Boiling Point | 509.3ºC at 760 mmHg |
| Molecular Formula | C20H24N2O |
| Molecular Weight | 308.41700 |
| Flash Point | 261.8ºC |
| Exact Mass | 308.18900 |
| PSA | 55.12000 |
| LogP | 4.30780 |
| Index of Refraction | 1.585 |
|
~69%
74517-78-5 |
| Literature: Eli Lilly and Company Patent: US4486592 A1, 1984 ; |
|
~%
74517-78-5 |
| Literature: Eli Lilly and Company Patent: US4277495 A1, 1981 ; |
|
~%
74517-78-5 |
| Literature: Eli Lilly and Company Patent: US4277495 A1, 1981 ; |
|
~%
74517-78-5 |
| Literature: Eli Lilly and Company Patent: US4486592 A1, 1984 ; |
| Precursor 3 | |
|---|---|
| DownStream 0 | |